Structure Therapeutics (GPCR) Non-cash Items (2022 - 2025)
Structure Therapeutics (GPCR) recorded quarterly Non-cash Items of $75.5 million in Q4 2025, up 50.12% quarter-over-quarter from $50.3 million in Q4 2024, and up 50.12% on a YoY basis from $50.3 million in Q4 2024.
Structure Therapeutics (GPCR) Non-cash Items (2022 - 2025) Analysis & Trends
Structure Therapeutics' Non-cash Items history runs 4 years deep, the most recent figure standing at $75.5 million for Q4 2025.
- In Q4 2025, Non-cash Items rose 50.12% year-over-year to $75.5 million; the TTM figure through Dec 2025 stood at $75.5 million (up 50.12% YoY), while the FY2025 annual figure was $75.5 million, up 1032.27% from the prior year.
- Non-cash Items was $75.5 million for Q4 2025 at Structure Therapeutics, up from $50.3 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $127.9 million in Q2 2023 to a low of $3.1 million in Q1 2023.
- Historically, Non-cash Items has averaged $54.2 million across 4 years, with a median of $52.3 million in 2024.
- Biggest YoY gain for Non-cash Items was 1207.69% in 2024; the steepest drop was 57.05% in 2024.
- A 4-year view of Non-cash Items shows it stood at $13.3 million in 2022, then soared by 781.53% to $117.1 million in 2023, then tumbled by 57.05% to $50.3 million in 2024, then jumped by 50.12% to $75.5 million in 2025.
- The last three Non-cash Items figures came in at $75.5 million (Q4 2025), $50.3 million (Q4 2024), and $54.4 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Structure Therapeutics | 9.35 Bn | 9.35 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 75.50 Mn |
| Dec 31, 2025 | 75.50 Mn |
| Dec 31, 2024 | 50.29 Mn |
| Dec 31, 2024 | 50.29 Mn |
| Sep 30, 2024 | 54.40 Mn |
| Sep 30, 2024 | 54.40 Mn |
| Jun 30, 2024 | 91.10 Mn |
| Jun 30, 2024 | 91.10 Mn |
| Mar 31, 2024 | 5.21 Mn |
| Mar 31, 2024 | 5.21 Mn |
| Dec 31, 2023 | 117.09 Mn |
| Dec 31, 2023 | 117.09 Mn |
| Sep 30, 2023 | 4.16 Mn |
| Sep 30, 2023 | 4.16 Mn |
| Jun 30, 2023 | 127.87 Mn |
| Jun 30, 2023 | 127.87 Mn |
| Mar 31, 2023 | 3.09 Mn |
| Mar 31, 2023 | 3.09 Mn |
| Dec 31, 2022 | 13.28 Mn |
| Dec 31, 2022 | 13.28 Mn |